Measures of high-density lipoprotein function in men and women with severe aortic stenosis.
Aortic stenosis
Calcification
Cholesterol efflux capacity
High-density lipoprotein
Valve
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
28 May 2022
28 May 2022
Historique:
received:
22
12
2021
accepted:
26
04
2022
entrez:
1
6
2022
pubmed:
2
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Calcification of the aortic valve is a common heart valve disorder, in some cases leading to clinically impactful severe aortic stenosis (AS). Sex-specific differences in aortic valve calcification (ACV) exist, with women having a lower burden of calcification than men as measured by computed tomography; however, the pathophysiological mechanism that leads to these differences remains unclear. Using cultured human Tamm-Horsfall protein 1 (THP-1) macrophages and human aortic valve interstitial cells, the effects of high-density lipoprotein (HDL) particles isolated from the plasma of men and women with severe AS were studied for cholesterol efflux capacity (CEC). HDL-CEC was assessed in 46 patients with severe AS, n = 30 men, n = 16 women. ATP-Binding Cassette A1 (ABCA1)-mediated HDL-CEC was measured from human cultured THP-1 macrophages to plasma HDL samples. Women with severe AS had more ABCA1-mediated HDL-CEC, as compared to men (8.50 ± 3.90% cpm vs. 6.80 ± 1.50% cpm, P = 0.04). HDL pre-β1 and α-particles were higher in woman than in men by spectral density, (pre-β1 HDL, 20298.29 ± 1076.15 vs. 15,661.74 ± 789.00, P = 0.002, and α-HDL, 63006.35 ± 756.81 vs. 50,447.00 ± 546.52, P = 0.03). Lecithin-cholesterol acyltransferase conversion of free cholesterol into cholesteryl esters was higher in women than men (16.44 ± 9.11%/h vs. 12.00 ± 8.07%/h, P = 0.03). Sex-specific changes in various parameters of HDL-CEC were found in patients with severe AS. Sex-based modifications in HDL functionality by HDL-CEC might account for the reduced burden of calcification in women vs. men with severe AS. Therefore, future studies should target sex-related pathways in AS to help to improve understanding and treatment of AS. Sex specifc differences in AVC and differences associated with HDL function in men and women with severe AS. When compared to men, women had higher preβ-HDL and α-HDL migrating particles, higher cholesterol efflux to HDL, and higher lecithin cholesterol acyl transferase (LCAT) activity, possibly indicating that improved reverse cholesterol transport may be protective against worsened calcification.
Sections du résumé
BACKGROUND
BACKGROUND
Calcification of the aortic valve is a common heart valve disorder, in some cases leading to clinically impactful severe aortic stenosis (AS). Sex-specific differences in aortic valve calcification (ACV) exist, with women having a lower burden of calcification than men as measured by computed tomography; however, the pathophysiological mechanism that leads to these differences remains unclear.
METHODS
METHODS
Using cultured human Tamm-Horsfall protein 1 (THP-1) macrophages and human aortic valve interstitial cells, the effects of high-density lipoprotein (HDL) particles isolated from the plasma of men and women with severe AS were studied for cholesterol efflux capacity (CEC).
RESULTS
RESULTS
HDL-CEC was assessed in 46 patients with severe AS, n = 30 men, n = 16 women. ATP-Binding Cassette A1 (ABCA1)-mediated HDL-CEC was measured from human cultured THP-1 macrophages to plasma HDL samples. Women with severe AS had more ABCA1-mediated HDL-CEC, as compared to men (8.50 ± 3.90% cpm vs. 6.80 ± 1.50% cpm, P = 0.04). HDL pre-β1 and α-particles were higher in woman than in men by spectral density, (pre-β1 HDL, 20298.29 ± 1076.15 vs. 15,661.74 ± 789.00, P = 0.002, and α-HDL, 63006.35 ± 756.81 vs. 50,447.00 ± 546.52, P = 0.03). Lecithin-cholesterol acyltransferase conversion of free cholesterol into cholesteryl esters was higher in women than men (16.44 ± 9.11%/h vs. 12.00 ± 8.07%/h, P = 0.03).
CONCLUSIONS
CONCLUSIONS
Sex-specific changes in various parameters of HDL-CEC were found in patients with severe AS. Sex-based modifications in HDL functionality by HDL-CEC might account for the reduced burden of calcification in women vs. men with severe AS. Therefore, future studies should target sex-related pathways in AS to help to improve understanding and treatment of AS. Sex specifc differences in AVC and differences associated with HDL function in men and women with severe AS. When compared to men, women had higher preβ-HDL and α-HDL migrating particles, higher cholesterol efflux to HDL, and higher lecithin cholesterol acyl transferase (LCAT) activity, possibly indicating that improved reverse cholesterol transport may be protective against worsened calcification.
Identifiants
pubmed: 35643498
doi: 10.1186/s12944-022-01653-7
pii: 10.1186/s12944-022-01653-7
pmc: PMC9148512
doi:
Substances chimiques
High-Density Lipoproteins, Pre-beta
0
Lecithins
0
Lipoproteins, HDL
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
48Informations de copyright
© 2022. The Author(s).
Références
Eur Cardiol. 2015 Winter;10(2):108-112
pubmed: 27274771
J Heart Valve Dis. 2010 Sep;19(5):653-64
pubmed: 21053746
Br J Pharmacol. 2008 Jun;154(4):765-73
pubmed: 18414386
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2714-2727
pubmed: 32907368
Eur J Clin Invest. 2013 Apr;43(4):317-23
pubmed: 23397902
J Mol Histol. 2020 Oct;51(5):559-571
pubmed: 32794037
Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):885-900
pubmed: 32160774
Eur Heart J Cardiovasc Imaging. 2021 Apr 28;22(5):581-588
pubmed: 32500142
Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):457-62
pubmed: 24334872
Heart. 2021 Sep;107(18):1493-1502
pubmed: 34083406
J Lipid Res. 2008 May;49(5):1006-14
pubmed: 18252847
Circulation. 2017 Jun 20;135(25):2494-2504
pubmed: 28450350
J Lipid Res. 2003 Jul;44(7):1373-80
pubmed: 12700343
J Am Soc Nephrol. 2003 Mar;14(3):732-8
pubmed: 12595510
N Engl J Med. 2013 Feb 7;368(6):503-12
pubmed: 23388002
Atherosclerosis. 2011 Dec;219(2):538-44
pubmed: 21917259
J Lipid Res. 1982 Jul;23(5):680-91
pubmed: 6811681
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E460-E468
pubmed: 29870675
Int J Mol Sci. 2020 Aug 06;21(16):
pubmed: 32781508
N Engl J Med. 2011 Jan 13;364(2):127-35
pubmed: 21226578
Curr Atheroscler Rep. 2021 Mar 27;23(6):23
pubmed: 33772657
Exp Gerontol. 2020 Oct 15;140:111075
pubmed: 32861845
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1828-36
pubmed: 17510466
Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1589-99
pubmed: 9763531
J Am Coll Cardiol. 1997 Mar 1;29(3):630-4
pubmed: 9060903
J Am Coll Cardiol. 2014 Sep 23;64(12):1202-13
pubmed: 25236511
J Clin Lipidol. 2018 Jul - Aug;12(4):1072-1082
pubmed: 29793828
Lancet Diabetes Endocrinol. 2015 Jul;3(7):507-13
pubmed: 26025389
Atherosclerosis. 2016 Mar;246:318-24
pubmed: 26828749
N Engl J Med. 2014 Dec 18;371(25):2383-93
pubmed: 25404125
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2148-2159
pubmed: 30026273
J Vis Exp. 2017 Nov 20;(129):
pubmed: 29286439
Heart Vessels. 2017 Feb;32(2):217-228
pubmed: 27761653
J Cardiovasc Comput Tomogr. 2010 Jan-Feb;4(1):41-6
pubmed: 20159627
Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2168-2179
pubmed: 31034990
Physiol Res. 1996;45(1):65-73
pubmed: 8884926
Physiology (Bethesda). 2017 May;32(3):182-196
pubmed: 28404735
Atherosclerosis. 1979 Nov;34(3):319-27
pubmed: 518742
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):40-7
pubmed: 23233744
Front Cardiovasc Med. 2019 Apr 16;6:49
pubmed: 31041314
Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):163-71
pubmed: 19306528
JAMA. 2014 Nov 5;312(17):1764-71
pubmed: 25344734
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1902-1910
pubmed: 31462089
Circulation. 2018 Jul 24;138(4):377-393
pubmed: 29588317
Atherosclerosis. 2015 Dec;243(2):631-7
pubmed: 26551591
Aging (Albany NY). 2021 May 11;13(9):12710-12732
pubmed: 33973531
Eur Heart J. 2016 Feb 21;37(8):693-9
pubmed: 26508159